Phase 2 (months 3–6)In development
Infusion Reimbursement & Site-of-Care Defence
Defending infusion reimbursement against site-of-care and white-bagging pressure.
Fig.Build schedule
Juris 340B SolutionsKNOWLEDGE.COMPLIANCE.IMPACT.Services
340B expertise designed around compliance, control and performance.
WholesalerPharmacy
ManufacturerCovered entityPatient
- 01340B Program ManagementProgram structure · oversight · optimization
- 02Audit & ComplianceReadiness · documentation · controls
- 03Contract PharmacyAgreements · reconciliation · restrictions
- 04Program OptimizationSavings · recovery · opportunity sizing
- 05Data & ReportingAccumulators · Medicaid exclusion · claims testing
- 06Strategic ConsultingInfusion · site of care · growth
Within 340B Program Management
340B Expertise
The program explained plainly, and the covered entities it was built for.
Learn 340B
- 01What is 340B?A plain-English explainer of the program and who it's for.
- 02How 340B WorksFollow one drug through the program, step by step.
- 03Covered EntitiesAll fourteen eligibility categories, explained.
- 04Contract PharmacyArrangements, oversight, and manufacturer restrictions.
- 05Duplicate DiscountsCarve-in versus carve-out, explained plainly.
- 06HRSA AuditsWhat HRSA examines, and why entities fail.
Who we serve
- 07Hospitals & Health SystemsDSH, RRC, SCH, children's hospitals.
- 08Critical Access & Rural HospitalsGPO-exempt, small teams, big exposure.
- 09Oncology & Infusion CentersWhere 340B and reimbursement meet.
- 10FQHCs & Look-AlikesHealth centers and RHCs.
- 11Ryan White HIV/AIDS ClinicsHigh concentration, high stakes.
- 12Every covered-entity category
Solutions
Instruments for measuring where a program stands, and evidence of what we deliver.
Interactive tools
- 01Restriction MatrixEvery manufacturer contract-pharmacy restriction, filterable.
- 02State Law TrackerStatus, scope and penalties by state, updated regularly.
- 03Audit ScorecardA 25-question self-assessment with an instant score.
- 04Rebate CalculatorModel the working-capital impact of the rebate model.
- 05Infusion ModelChairs, utilization, payer mix and 340B overlay in one model.
Outcomes
- 06Case StudiesRepresentative engagements, filterable by entity type.
- 07Our processAssess, quantify, remediate, sustain — the four phases behind every engagement.
- 08Pricing & engagementHow engagements are scoped and priced, in plain terms.
- 09Resource centerEvery guide, tool and reference, filterable by entity type.